IP Library Patent Application 13706061
Patent Application
App. No. 13/706,061

BRONCHOSCOPIC LUNG VOLUME REDUCTION METHOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/706,061
Abstract

A method of minimally invasively reducing a volume of a hyper-inflated target section of diseased lung comprising the steps of introducing a bronchoscope into a patient's airway to a position adjacent the target section and equilibrating air within the target section with atmospheric air to at least partially deflate the target lung section; injecting an inflammation-causing substance into the target section to precipitate adhesion of the walls within the target lung section, preventing substantial re-inflation of the target section by occluding an airway upstream of the target section for a period of time, and removing the airway occlusion after the target section has substantially permanently been reduced in volume. The injected substance can be autologous blood or a constituent thereof.

Claims (18)

1 . A system for the reduction of lung volume, the system comprising:

a bronchoscope with a proximal end and a distal end, the bronchoscope capable of being inserted into a lung and navigated proximate a target region of a lung, the bronchoscope further comprising at least one channel extending from the proximal end to the distal end of the bronchoscope;

a lung occlusion device capable of substantially preventing air and fluid flow past itself when deployed into a lung airway;

a source of gas, wherein the gas is an inflammation-triggering gas for treating the target region of the lung; and

a catheter capable of being inserted into the bronchoscope lumen, the catheter comprising a first lumen configured to communicate with the source of gas and the target region of the lung, the catheter being further configured to deploy the lung occlusion device.

2 . The system of claim 1 , wherein the gas is a vapor.

3 . The system of claim 1 , wherein the gas is a heated gas.

4 . The system of claim 1 , wherein the gas is configured to precipitate adhesion of walls of the diseased target region.

5 . The system of claim 1 , wherein the gas is configured to reduce hyper-inflation of the diseased target region.

6 . The system of claim 1 , wherein the occlusion device is a one-way valve configured to allow the flow of fluid in one direction and substantially preclude the flow of fluid in an opposite direction.

7 . The system of claim 6 , wherein the one-way valve is a stent-supported valve.

8 . The system of claim 1 , wherein the occlusion device is a plug-type occlusion device.

9 . The system of claim 1 , wherein the occlusion device is configured to preclude migration of the gas to non-targeted regions of the lung.

10 . The system of claim 1 , wherein the catheter comprises a puncturing tip.

11 . The system of claim 10 , wherein the puncturing tip is in fluid communication with the first lumen.

12 . The system of claim 1 , wherein the catheter further comprises a second lumen, wherein the second lumen is configured to contain and deliver the lung occlusion device.

13 . The system of claim 1 , wherein the occlusion device comprises bioabsorbable polymer.

14 . The system of claim 1 , wherein the catheter comprises a pressure gauge or sensor for indicating an air pressure level at a distal end of the catheter.

Assignments (1)
MERGER Recorded Apr 15, 2020
From: SPIRATION, INC.
To: GYRUS ACMI, INC.
Reel/Frame 052401/0484 →